Singapore’s growing longevity industry uses metabolic monitoring, genetic tests, supplements and oxygen therapy to slow ageing, with some clients aiming to cut 20 years from their biological age. The global healthy-ageing market, worth $19–20 billion in 2023, could more than triple by 2035.